Amulan, Cungan M.
HRN: 11-09-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2024
CEFTAZIDIME 1GM (VIAL)
05/31/2024
06/06/2024
IV
1g
Q8h
Cap-mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes